Sandra Garcet Selected Research

Interleukin-17 Receptors

1/2020

Short-term transcriptional response to IL-17 receptor-A antagonism in the treatment of psoriasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sandra Garcet Research Topics

Disease

28	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2023 - 01/2017
13	Inflammation (Inflammations) 10/2023 - 01/2017
7	Hidradenitis Suppurativa 05/2024 - 11/2020
7	Atopic Dermatitis (Atopic Eczema) 01/2022 - 01/2016
5	Hyperplasia 01/2022 - 01/2017
3	Melanoma (Melanoma, Malignant) 09/2023 - 10/2016
3	Alopecia Areata 01/2023 - 01/2022
2	Skin Diseases (Skin Disease) 05/2024 - 01/2022
2	Alopecia (Baldness) 10/2022 - 01/2022
1	Body Weight (Weight, Body) 01/2023
1	Cicatrix (Scar) 01/2023
1	Ulcerative Colitis 11/2022
1	Erythema 01/2021
1	Obesity 01/2020
1	Necrosis 01/2020
1	Parakeratosis 01/2020
1	Dermatitis 10/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Keloid 01/2017
1	Neoplasm Metastasis (Metastasis) 10/2016

Drug/Important Bio-Agent (IBA)

12	Interleukin-17 (Interleukin 17)IBA 10/2023 - 11/2017
9	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2017
9	CytokinesIBA 01/2023 - 01/2017
8	Ustekinumab (CNTO 1275)FDA Link 10/2023 - 01/2017
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2017
4	secukinumabIBA 10/2023 - 01/2021
3	dupilumabIBA 01/2023 - 01/2022
3	Keratin-16 (Keratin 16)IBA 01/2022 - 01/2017
3	brodalumabIBA 01/2022 - 01/2020
3	Interleukin-22 (IL-22)IBA 01/2020 - 01/2018
2	guselkumabIBA 10/2023 - 01/2023
2	Interleukin-23 (Interleukin 23)IBA 01/2023 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2019
2	SaltsIBA 10/2022 - 01/2022
2	ProteomeIBA 01/2022 - 01/2021
2	Lipocalin-2IBA 01/2022 - 01/2021
2	Monoclonal AntibodiesIBA 01/2022 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 10/2019
2	Blood Proteins (Serum Proteins)IBA 01/2022 - 01/2018
2	loricrinIBA 01/2021 - 01/2019
2	Filaggrin ProteinsIBA 01/2021 - 01/2019
2	SteroidsIBA 01/2021 - 01/2016
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2017
2	Interleukin-12 (IL 12)IBA 01/2019 - 01/2017
2	fezakinumabIBA 01/2019 - 01/2018
2	Etanercept (Enbrel)FDA Link 01/2019 - 01/2018
1	Antigen-Antibody Complex (Immune Complex)IBA 05/2024
1	Phosphotransferases (Kinase)IBA 09/2023
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023
1	Small Cytoplasmic RNAIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	4-nitrophenyl phenylphosphonateIBA 01/2023
1	pneumococcal purpura-producing principle (PPPP)IBA 01/2023
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2022
1	InterleukinsIBA 01/2022
1	spesolimabIBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 11/2021
1	Abatacept (Orencia)FDA Link 11/2021
1	ropsacitinibIBA 03/2021
1	TYK2 Kinase (Tyrosine Kinase 2)IBA 03/2021
1	S100 Calcium Binding Protein A7IBA 01/2021
1	Cathepsin DIBA 01/2021
1	MART-1 AntigenIBA 01/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020
1	InterferonsIBA 01/2020
1	Janus Kinase 1IBA 01/2020
1	PF-06700841IBA 01/2020
1	Interleukin-17 ReceptorsIBA 01/2020
1	Imiquimod (Aldara)FDA LinkGeneric 10/2019
1	AnisomycinIBA 10/2019
1	p38 Mitogen-Activated Protein KinasesIBA 10/2019
1	doramapimodIBA 10/2019
1	Interleukin-23 Subunit p19IBA 01/2019
1	risankizumabIBA 01/2019
1	apremilastIBA 01/2018
1	tofacitinibIBA 01/2018
1	LipidsIBA 11/2017
1	Phospholipases A2 (Phospholipase A2)IBA 11/2017
1	AntigensIBA 11/2017
1	AutoantigensIBA 11/2017
1	Metalloproteases (Metalloproteinases)IBA 11/2017
1	CathelicidinsIBA 11/2017
1	DisintegrinsIBA 11/2017
1	ThrombospondinsIBA 11/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2017
1	Fibrillin-2IBA 01/2017
1	Collagen Type XIBA 01/2017
1	osteoblast cadherinIBA 01/2017
1	OsteopontinIBA 01/2017
1	diphenylcyclopropenoneIBA 10/2016

Therapy/Procedure

3	Therapeutics 01/2023 - 11/2017
3	Aftercare (After-Treatment) 01/2023 - 01/2022
1	Lasers (Laser) 09/2023
1	Retreatment 01/2020